These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25654080)

  • 1. Management of moderate to severe psoriasis in patients with metabolic comorbidities.
    Gisondi P; Galvan A; Idolazzi L; Girolomoni G
    Front Med (Lausanne); 2015; 2():1. PubMed ID: 25654080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities.
    Gisondi P; Bellinato F; Girolomoni G; Albanesi C
    Front Pharmacol; 2020; 11():117. PubMed ID: 32161545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiometabolic comorbidities and the approach to patients with psoriasis.
    Gisondi P; Girolomoni G
    Actas Dermosifiliogr; 2009 Dec; 100 Suppl 2():14-21. PubMed ID: 20096157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored biological treatment for patients with moderate-to-severe psoriasis.
    Maurelli M; Gisondi P; Girolomoni G
    Expert Rev Clin Immunol; 2023 Jan; 19(1):37-43. PubMed ID: 36300752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psoriatic patient profile for infliximab.
    Gisondi P; Malara G; Ardigò M
    Eur Rev Med Pharmacol Sci; 2011 Dec; 15(12):1445-51. PubMed ID: 22288305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis and Vascular Risk : An Update.
    Katsiki N; Anagnostis P; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2014; 20(39):6114-25. PubMed ID: 24745923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis, the liver, and the gastrointestinal tract.
    Gisondi P; Del Giglio M; Cozzi A; Girolomoni G
    Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psoriasis comorbidities].
    Gkalpakiotis S
    Cas Lek Cesk; 2017; 156(3):119-122. PubMed ID: 28722453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond skin deep: addressing comorbidities in psoriasis.
    Kovitwanichkanont T; Chong AH; Foley P
    Med J Aust; 2020 Jun; 212(11):528-534. PubMed ID: 32388913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.
    Gisondi P; Girolomoni G
    Semin Thromb Hemost; 2009 Apr; 35(3):313-24. PubMed ID: 19452407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concept of Remission in Chronic Plaque Psoriasis.
    Gisondi P; Di Mercurio M; Idolazzi L; Girolomoni G
    J Rheumatol Suppl; 2015 Nov; 93():57-60. PubMed ID: 26523059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic comorbidities of psoriasis (Review).
    Branisteanu DE; Pirvulescu RA; Spinu AE; Porumb EA; Cojocaru M; Nicolescu AC; Branisteanu DC; Branisteanu CI; Dimitriu A; Alexa AI; Toader MP
    Exp Ther Med; 2022 Feb; 23(2):179. PubMed ID: 35069860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of psoriasis as a systemic disease: what is the evidence?
    Korman NJ
    Br J Dermatol; 2020 Apr; 182(4):840-848. PubMed ID: 31225638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring psoriatic disease in clinical practice. An expert opinion position paper.
    Lubrano E; Cantini F; Costanzo A; Girolomoni G; Prignano F; Olivieri I; Scarpa R; Spadaro A; Atzeni F; Narcisi A; Ricceri F; Sarzi-Puttini P
    Autoimmun Rev; 2015 Oct; 14(10):864-74. PubMed ID: 26025585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Position statement for the management of comorbidities in psoriasis.
    Dauden E; Blasco AJ; Bonanad C; Botella R; Carrascosa JM; González-Parra E; Jodar E; Joven B; Lázaro P; Olveira A; Quintero J; Rivera R
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2058-2073. PubMed ID: 29992631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities in Psoriatic Arthritis.
    Husni ME
    Rheum Dis Clin North Am; 2015 Nov; 41(4):677-98. PubMed ID: 26476226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease and psoriasis: So far, so near.
    Ganzetti G; Campanati A; Offidani A
    World J Hepatol; 2015 Mar; 7(3):315-26. PubMed ID: 25848461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects and comorbidities of psoriasis.
    Ayala F; Ayala F
    J Rheumatol Suppl; 2009 Aug; 83():19-20. PubMed ID: 19661531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.